DOLENE
|
American Cyanamid Co
|
Quote
|
DARVON COMPOUND-65
|
Eli Lilly and Company
|
Quote
|
SK-65
|
Glaxosmithkline Holdings Americas
|
Quote
|
NDC00005-3123-31
|
American Cyanamid Co
|
Quote
|
NDC00002-3111-03
|
Eli Lilly and Company
|
Quote
|
NDC00007-0468-25
|
Glaxosmithkline Holdings Americas
|
Quote
|
DARVON COMPOUND-65
|
Eli Lilly and Company
|
Quote
|
SK-65
|
Glaxosmithkline Holdings Americas
|
Quote
|
NDC00002-3111-03
|
Eli Lilly and Company
|
Quote
|
NDC00007-0468-25
|
Glaxosmithkline Holdings Americas
|
Quote
|
DOLENE
|
American Cyanamid Co
|
Quote
|
NDC00005-3123-31
|
American Cyanamid Co
|
Quote
|
DARVON COMPOUND-65
|
Eli Lilly and Company
|
Quote
|
SK-65
|
Glaxosmithkline Holdings Americas
|
Quote
|
NDC00002-3111-03
|
Eli Lilly and Company
|
Quote
|
NDC00007-0468-25
|
Glaxosmithkline Holdings Americas
|
Quote
|
DOLENE
|
American Cyanamid Co
|
Quote
|
NDC00005-3123-31
|
American Cyanamid Co
|
Quote
|
DARVON COMPOUND-65
|
Eli Lilly and Company
|
Quote
|
SK-65
|
Glaxosmithkline Holdings Americas
|
Quote
|
NDC00002-3111-03
|
Eli Lilly and Company
|
Quote
|
NDC00007-0468-25
|
Glaxosmithkline Holdings Americas
|
Quote
|
NDC00005-3123-31
|
American Cyanamid Co
|
Quote
|
DOLENE
|
American Cyanamid Co
|
Quote
|